FDA Announces Public Meeting of Oncologic Drugs Advisory Committee and Requests Comments

Summary

The US Food and Drug Administration (FDA) is hosting a public meeting of its Oncologic Drugs Advisory Committee and is seeking public input on the meeting and its agenda, with the goal of informing the committee's discussions and recommendations.